Tissue transglutaminase (TG2) significantly induces epithelial-mesenchymal transition (EMT), which enhances tumor invasiveness and metastatic properties in conjunction with TGF- and NF-κB signaling, indicating a strong correlation between TG2, inflammation, and cancer [16,17]. This evidence concerns the gene TGM2 and neoplasm.